Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9745 Download: 88 Web of Science: 13 Crossref: 12

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C

Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2012;18(4):360-367. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.360

View: 7828 Download: 35 Crossref: 13

Case Report

A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage

Ju Seung Kim, Young Rock Jang, Ji Won Lee, Jin Yong Kim, Young Kul Jung, Dong Hae Chung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2011;17(3):229-232. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.229

View: 9950 Download: 64 Crossref: 8

Original Article

Genetic polymorphism at codon 10 of the transforming growth factor-β1 gene in patients with alcoholic liver cirrhosis

Jong Joon Lee, Soo Kyung Park, Oh Sang Kwon, In Sik Won, Dong Kyu Kim, Young Kul Jung, Yang Suh Ku, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2011;17(1):37-43. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.37

View: 7152 Download: 61 Crossref: 4

Factors influencing the severity of acute viral hepatitis A

Joo Il Kim, Yun Soo Kim, Young Kul Jung, Oh Sang Kwon, Yeon Suk Kim, Yang Suh Ku, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2010;16(3):295-300. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.295

View: 7734 Download: 84 Crossref: 16

1 |

Viewed By 4934	MAFLD: How is it different from NAFLD?
Viewed By 4828	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4727	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4445	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4402	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search